Capricor Therapeutics (CAPR) Shares Surge on Positive Phase 3 Data for Duchenne Therapy

As reported by gurufocus.com

On September 29, 2026, Capricor Therapeutics Inc (NASDAQ: CAPR) saw a notable increase in its share price following the presentation of new Phase 3 HOPE-3 trial...

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on gurufocus.com ↗

Market Samachar is a news aggregator. This article was originally published by gurufocus.com. Tap the button above to read the full story on their site.

INDIAN Inox Clean Energy files DRHP for Rs 10,000 crore IPO. Check details Markets-Economic Times
INDIAN Stock Market LIVE: Sensex, Nifty stuck in range; Coforge, OFSS lead MidCap gains Share Market Today
INDIAN Solar Industries shares up over 6%! What's driving defence stock that has surged 60% in YTD | Check target price mint - markets
INDIAN Tega Industries shares jump 6% | What’s driving the stock’s 30% monthly rally? mint - markets
CRYPTO XRP Ledger starts carrying fund records from Brazil operator overseeing $4 trillion CoinDesk: Bitcoin, Ethereum, Crypto News and Price Data
GLOBAL Drop in donations puts community pantry at risk BBC News
COMPANIES Cupid, Sterlite Tech among 10 smallcap stocks set for sharp fund flows after Nifty rejig. See full list Stocks-Markets-Economic Times
INDIAN Parag Thakkar Bets On HDFC Bank At Rs 925, Sees Nearly 30% Upside NDTV Profit - Latest

Capricor Therapeutics (CAPR) Shares Surge on Positive Phase 3 Data for Duchenne Therapy

More from Market Samachar